IBMs, Earnings

IBM's Earnings Verdict Looms: Can a $10 Billion Quantum Bet Survive a Crisis of Confidence?

Published on 07/22/2026 at 02:51 | Redaktion boerse-global.de

IBM reports Q2 results amid a 29% stock drop, testing CEO Krishna's claim that AI-driven budget shifts are temporary, not structural.

IBM Q2 Earnings: Quantum Bet vs. 29% Stock Plunge and AI Cannibalization
IBM's Earnings Verdict Looms: Can a $10 Billion Quantum Bet Survive a Crisis of Confidence? Illustration mit AI erstellt übermittelt durch boerse-global.de

When IBM reports its full second-quarter results after the closing bell today, the company isn't just delivering routine financials. It's attempting to salvage a narrative that has unraveled with alarming speed — a story that pits a decade-long, $10 billion bet on quantum computing against the brutal reality of a stock that has shed nearly 29% of its value since January.

The tension couldn't be starker. On one side, CEO Arvind Krishna is doubling down on a vision of fault-tolerant quantum machines by 2029, backed by massive investments in chip fabrication and enterprise AI. On the other, the market is fixated on a far more immediate question: Was the preliminary earnings warning on July 14 a temporary hiccup, or the first sign that IBM's core business is being cannibalized by the very AI boom it's trying to ride?

The Numbers That Started the Panic

The preliminary figures already painted an uncomfortable picture. Revenue crept up just 1% to $17.2 billion. Software managed a 5% gain, with Red Hat accelerating to 11% growth, but consulting flatlined and infrastructure cratered 7%. GAAP diluted earnings per share slipped 2% to $2.27. Gross margins tightened.

The market's response was brutal. Shares plunged as much as 25% in a single session, wiping out roughly $68 billion in market value. That sell-off has left IBM trading at €184.58 — barely 3% above its 52-week low of €178.52. The stock now sits 21% below its 200-day moving average of €234.74, and the gap to its June 1 high of €292.85 stands at a staggering 37%.

Should investors sell immediately? Or is it worth buying IBM?

A CEO's Explanation — and a Credibility Test

Krishna attributed the second-quarter weakness to a specific, temporary phenomenon. In the final weeks of June, he explained, corporate clients pulled forward their quarterly budgets to lock in server, storage, and memory purchases ahead of expected price increases driven by tight hardware supply. This artificial demand surge, he argued, distorted normal purchasing patterns and will correct itself in the second half.

The problem? The same hardware and mainframe business that disappointed investors is precisely the area where Krishna is asking for patience. The new z17 mainframe cycle, while still running at about 130% of the prior z16 generation's pace, has seen several large orders delayed or canceled as clients redirect budgets toward AI infrastructure — specialized servers, storage systems, and memory chips.

Today's full report will test whether that explanation holds water. The key metric isn't the quarter itself — its broad contours are already known — but the forward guidance. If management reaffirms its 2026 target of at least 5% currency-adjusted revenue growth and confirms that delayed deals have closed or are firmly booked for Q3, the market may treat the sell-off as an overreaction. A downgrade below that 5% threshold, however, would validate fears that IBM's high-margin software business is being structurally squeezed by the AI infrastructure buildout.

The Quantum Paradox

Against this backdrop of short-term turmoil, IBM is making its most aggressive long-term bet in decades. The company has committed more than $10 billion over the next five years to build a large-scale, fault-tolerant quantum computer by 2029, including backing for the planned Anderon wafer fabrication facility for quantum chips.

The timing is awkward. Krishna is essentially asking investors to look past a weak quarter and focus on a five-year hardware roadmap — at a moment when the company's current hardware business is its biggest disappointment. The quantum investment, however visionary, does nothing to address the immediate question of whether AI spending is pulling dollars away from IBM's software and consulting franchises.

The 14-day relative strength index of 31.1 signals deeply oversold conditions, and analyst price targets ranging from €257 to €272 suggest significant upside if confidence returns. But the annualized 30-day volatility of nearly 84% indicates a stock still searching for a floor, not settling into a range.

IBM at a turning point? This analysis reveals what investors need to know now.

What's at Stake Tonight

The earnings call at 5:00 PM ET will be the decisive moment. Investors will parse every word on two fronts: the health of the "distributed infrastructure" business and the trajectory of the software stack. A clear, confident reaffirmation of guidance could trigger a rapid recovery toward the 100-day moving average of €218.09. Vagueness or a downgrade would likely send shares below the €178.52 support level, opening the door to further losses.

Adding to the pressure, several law firms have launched investigations into potential securities fraud, examining whether management had adequate visibility into its own pipeline before the preliminary warning. Any suggestion in tonight's report that internal oversight was lacking would intensify that legal risk.

IBM may be right about where computing will stand in five years. But for a stock trading near its lowest point in a year, with a credibility crisis unfolding in real time, the market is pricing the next quarter — not the next decade. Tonight's report will determine whether that gap between vision and reality can begin to close.

Ad

IBM Stock: New Analysis - 22 July

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4592001014 | IBMS | boerse | 69828816 |